Department of Pharmaceutics, Shenyang Pharmaceutical University, Wenhua Road No. 103, Shenyang, China.
School of Functional Food and Wine, Shenyang Pharmaceutical University, Wenhua Road No. 103, Shenyang, China.
Nanoscale. 2023 May 25;15(20):8948-8971. doi: 10.1039/d3nr00867c.
Chemodynamic therapy (CDT), a novel therapeutic approach based on Fenton (Fenton-like) reaction, has been widely employed for tumor therapy. This approach utilizes Fe, Cu, or other metal ions (Mn, Zn, Co, or Mo) to react with the excess hydrogen peroxide (HO) in tumor microenvironments (TME), and form highly cytotoxic hydroxyl radical (˙OH) to kill cancer cells. Recently, nanoscale metal-organic frameworks (nMOFs) have attracted considerable attention as promising CDT agents with the rapid development of cancer CDT. This review focuses on summarizing the latest advances (2020-2022) on the design of nMOFs as nanomedicine for CDT or combination therapy of CDT and other therapies. The future development and challenges of CDT are also proposed based on recent progress. Our group hopes that this review will enlighten the research and development of nMOFs for CDT.
化学动力学治疗(CDT)是一种基于 Fenton(类 Fenton)反应的新型治疗方法,已广泛应用于肿瘤治疗。该方法利用 Fe、Cu 或其他金属离子(Mn、Zn、Co 或 Mo)与肿瘤微环境(TME)中过量的过氧化氢(HO)反应,形成高细胞毒性的羟基自由基(˙OH)来杀死癌细胞。最近,纳米级金属有机骨架(nMOFs)作为有前途的 CDT 试剂引起了广泛关注,随着癌症 CDT 的快速发展。本综述重点总结了 2020-2022 年 nMOFs 作为用于 CDT 的纳米药物或 CDT 与其他疗法联合治疗的设计的最新进展。还根据最近的进展提出了 CDT 的未来发展和挑战。我们希望这篇综述能够启发 nMOFs 在 CDT 中的研究和开发。
ACS Appl Mater Interfaces. 2021-9-29
Acc Chem Res. 2020-9-15
Adv Healthc Mater. 2022-1
ACS Appl Mater Interfaces. 2022-8-31
J Colloid Interface Sci. 2021-4